Texas Top Legal Officer Takes Legal Action Against Acetaminophen Makers Concerning Autism Spectrum Claims
The top legal official in Texas Ken Paxton is taking legal action against the makers of acetaminophen, claiming the corporations concealed alleged dangers that the drug created to children's brain development.
The lawsuit follows thirty days after Former President Trump advocated an unproven link between consuming acetaminophen - also known as acetaminophen - while pregnant and autism in children.
The attorney general is taking legal action against Johnson & Johnson, which previously sold the medication, the only pain reliever approved for pregnant women, and Kenvue, which now manufacturers it.
In a statement, he said they "betrayed America by making money from pain and promoting medication ignoring the risks."
Kenvue says there is insufficient reliable data tying acetaminophen to autism.
"These manufacturers misled for generations, deliberately risking millions to line their pockets," Paxton, from the Republican party, stated.
Kenvue commented that it was "seriously troubled by the dissemination of inaccurate information on the safety of acetaminophen and the potential impact that could have on the welfare of American women and children."
On its official site, the company also mentioned it had "consistently assessed the relevant science and there is insufficient valid information that demonstrates a verified association between using acetaminophen and autism."
Organizations representing medical professionals and medical practitioners share this view.
The leading OB-GYN organization has stated paracetamol - the primary component in Tylenol - is one of the few options for expectant mothers to address pain and elevated temperature, which can present significant medical dangers if not addressed.
"In more than two decades of studies on the use of paracetamol in gestation, zero credible investigations has conclusively proven that the consumption of acetaminophen in any trimester of gestation causes neurological conditions in offspring," the organization commented.
The lawsuit cites recent announcements from the former administration in arguing the medication is potentially dangerous.
Recently, Trump generated worry from health experts when he advised pregnant women to "struggle intensely" not to take Tylenol when sick.
Federal regulators then issued a notice that medical professionals should consider limiting the usage of Tylenol, while also mentioning that "a proven link" between the drug and autism in young ones has not been established.
The Health Department head Robert F Kennedy Jr, who supervises the FDA, had pledged in spring to conduct "a massive testing and research effort" that would identify the origin of autism spectrum disorder in a limited time.
But authorities warned that identifying a single cause of autism - believed by scientists to be the result of a intricate combination of inherited and external influences - would not be simple.
Autism spectrum disorder is a category of permanent neurological difference and impairment that influences how persons perceive and interact with the world, and is diagnosed using physician assessments.
In his court filing, the attorney general - aligned with the former president who is running for US Senate - asserts the manufacturer and J&J "willfully ignored and sought to suppress the science" around acetaminophen and autism spectrum disorder.
The case seeks to make the corporations "eliminate any commercial messaging" that asserts Tylenol is secure for women during pregnancy.
The Texas lawsuit parallels the complaints of a collection of mothers and fathers of young ones with autism and ADHD who sued the manufacturers of acetaminophen in 2022.
A federal judge rejected the legal action, saying research from the family's specialists was not conclusive.